Research and Development

Showing 15 posts of 9573 posts found.

novartis_side_building

Novartis aims to launch five major global biosimilars by 2020

June 21, 2016 Manufacturing and Production, Research and Development 2020, Novartis, Sandoz, biosimilars

Novartis (VTX: NOVN) has announced plans to triple its biosimilar portfolio by 2020, with the launch of five major biosimilar …
shutterstock_67313209

Doctors prescribe more brand drugs for free meals from pharma industry – Study

June 21, 2016 Manufacturing and Production, Research and Development, Sales and Marketing JAMA, regulation, research

Doctors who received free meals from the pharmaceutical representatives were more likely to prescribe the brand-name medication that was being …
aedes_aegypti_mosquito

First-in-man Zika vaccine trials get green light

June 21, 2016 Manufacturing and Production, Research and Development trials, zika vaccine

Inovio Pharmaceuticals (NASDAQ: INO) and GeneOne Life Science (KSE: 011000) have announced that approval has been granted for the commencement …
esteban

Amgen appoints Esteban Santos as executive VP of operations

June 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amgen (NASDAQ: AMGN) has announced the appointment of Esteban Santos as executive vice president, operations. Santos will be responsible for …
stocks1

Weekly Movers: Global Blood Therapeutics, Sophiris Bio…

June 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Global Blood Therapeutics, Shares, markets, pharma, stocks

Here’s a quick look at some of the biggest movers of the week:Sophiris Bio (Nasdaq: SPHS) stock rose to nearly …
nhs_sign

NHS looking to offer free healthcare apps, devices from next year

June 20, 2016 Medical Communications, Research and Development, Sales and Marketing DigitalHealth, HealthTech, NHS, NICE

The NHS will offer devices and apps for free to help patients manage their health, starting in UK next year.
gsk_boronia_australia

GSK triple combo COPD therapy shows superiority in Phase III trials

June 20, 2016 Research and Development, Sales and Marketing COPD, GSK, phase III

GlaxoSmithKline (LSE: GSK), along with Innoviva (NASDAQ: INVA), have presented positive top-line results from a pivotal Phase III trial for …

Chi-Med to get $10 million milestone from AstraZeneca after initiation of expanded Phase II trials in NSCLC

June 20, 2016 Research and Development, Sales and Marketing AstraZeneca, Chi-Med, Iressa, Tagrisso, drug trial, lung cancer

Hutchison China MediTech (Nasdaq: HCM) on Monday said it is expanding Phase II trials in non-small cell lung cancer to …
lab

Federal panel to review proposal for first human CRISPR test

June 20, 2016 Research and Development, Sales and Marketing crispr, gene editing, human testing, oncology

A US Federal safety board is set to review a proposal for the first human use of the gene editing …

Nice backs BMS’ combination immunotherapy Opdivo, Yervoy to treat skin cancer

June 17, 2016 Medical Communications, Research and Development, Sales and Marketing BMS, NICE, oncology, opdivo, regulation, skin cancer

The National Institute for Health and Care Excellence (Nice) has backed a combination of Bristol-Myers Squibb’s immunotherapy Opdivo (nivolumab) and …

Pfizer breaks ground on new $200 million biologics facility

June 17, 2016 Medical Communications, Research and Development Manufacturing Facility, Pfizer

Pfizer (NYSE: PFE) has broken ground on a new $200 million biologics clinical manufacturing facility in Andover, Massachusetts. This expansion …
6123892769_1befc31f38_o

WellBe bracelet, mobile app to help manage stress

June 17, 2016 Medical Communications, Research and Development HealthTech, WellBe, app, stress, wearable technology

Adding to the growing list of healthcare applications, a new technology claims to have created the first anti-stress biofeedback bracelet …
roche_close

Roche gets a NICE knockback for melanoma drug, Cotellic

June 16, 2016 Medical Communications, Research and Development, Sales and Marketing Cotellic, NICE, Roche

The National Institute for Health and Care Excellence (NICE) has announced that that it has not recommended Roche’s melanoma drug, …
chemo-web

SMC recommends treatment for potentially fatal chemotherapy-related disease

June 16, 2016 Research and Development, Sales and Marketing Menarini, SMC, adneuric

The Scottish Medicines Consortium has recommended Adenuric (febuxostat), a treatment for a severe complication that can affect chemotherapy patients in …
alzheimers_web_credit_shutterstock

Chiasma cuts staff by 33% after FDA rejects rare disease drug, Mycapssa

June 16, 2016 Research and Development, Sales and Marketing FDA, chiasma, cutbacks, failure, workforce cuts

US-based biopharmaceutical company, Chiasma (NASDAQ: CHMA), has announced substantial job cuts as it attempts to restructure following the US Food …
The Gateway to Local Adoption Series

Latest content